Huali Pharmaceutical Group

Huali is a diversified investment and development private enterprise group with Huali Group Co., Ltd. as the parent entity and multiple industrial group companies, focusing on industrial operations, industrial investment and integration. Founded on September 28, 1970, it became the largest enterprise in China's electrical instrument industry in 1993 and began to break away from the factory-based development model to make diversified investments to form industrial clusters. At present, Huali controls three A-share listed companies: Kunming Pharmaceutical Group (SH 600422), Jianmin Group (SH 600976) and Huazheng New Materials (SH 603186), and holds shares in two A-share listed companies, Huamei Holdings (SZ 000607) and Buchang Pharmaceuticals (SH 603858), as well as the NEEQ-listed Houda Intelligent (870688). It invests in and cultivates businesses in medical and health services, traditional Chinese medicine, prescription drug industry and precision medical services, clean energy and IoT industry, new materials industry, innovation and entrepreneurship services, etc. On the industrial foundation of "one main body and two wings", centering on users, families and communities, with community clinics as the entry point and the "1+30+3+n" medical and elderly care consortium as the breakthrough, it creates featured home-visit/nearby medical services and builds a new business format of healthy living in future communities.